A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures

Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: A comparison with carbamazepine, oxcarbazepine and lacosamide

(2015) Simon Hebeisen et al.   NEUROPHARMACOLOGY

Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug

(2014) Anna Doeser et al.   BRAIN

Safety of a dedicated brain MRI protocol in patients with a vagus nerve stimulator

(2014) Jeroen C. de Jonge et al.   EPILEPSIA

Psychosocial long-term outcome in juvenile myoclonic epilepsy

(2014) Martin Holtkamp et al.   EPILEPSIA

Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial

(2014) Michael R. Sperling et al.   EPILEPSIA

Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: Results of the 1-year ESLIBASE retrospective study

(2014) V. Villanueva et al.   EPILEPSY RESEARCH

SAFETY AND EFFICACY OF ESLICARBAZEPINE ACETATE (ZEBINIX) IN EVERYDAY CLINICAL PRACTICE USING A RETROSPECTIVE MULTICENTRE AUDIT

(2014) S Keogh et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy

(2013) Dong Wook Kim et al.   EPILEPSIA

Estudio postautorización de la eslicarbazepina en el tratamiento de epilepsias farmacorresistentes: resultados preliminares

(2013) A. Massot et al.   NEUROLOGIA

Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers

(2012) Teresa Nunes et al.   EPILEPSIA

Adherence to antiepilepsy drug therapy

(2012) Edward Faught   EPILEPSY & BEHAVIOR

Satisfaction with antiepileptic drugs in children and adolescents with newly diagnosed and chronic epilepsy

(2012) Ettore Beghi et al.   EPILEPSY RESEARCH

Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: Results of a 1-year open-label extension study

(2012) Andreas Hufnagel et al.   EPILEPSY RESEARCH

Long-term efficacy and safety of eslicarbazepine acetate: Results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy

(2010) Peter Halász et al.   EPILEPSIA

Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy

(2010) E. Ben-Menachem et al.   EPILEPSY RESEARCH

Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures

(2009) A. Gil-Nagel et al.   ACTA NEUROLOGICA SCANDINAVICA

Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial

(2009) Péter Halász et al.   EPILEPSIA

Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study

(2009) Christian Elger et al.   EPILEPSIA

Pharmacokinetics, Efficacy, and Tolerability of Eslicarbazepine Acetate in Children and Adolescents With Epilepsy

(2008) Luis Almeida et al.   JOURNAL OF CLINICAL PHARMACOLOGY